| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/09/2009 | EP2097109A2 Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production |
| 09/09/2009 | EP2097088A2 Muscle derived cells for the treatment of cardiac pathologies and methods of making and using the same |
| 09/09/2009 | EP2097080A2 Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels |
| 09/09/2009 | EP2097079A2 Modulation of prostaglandin/cyclooxygenase metabolic pathways |
| 09/09/2009 | EP1885382A4 Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
| 09/09/2009 | EP1670768B1 Compounds and methods for treating dyslipidemia |
| 09/09/2009 | EP1553923B1 Camptothecin-carboxylate formulations |
| 09/09/2009 | EP1515947B1 Fluorinated cycloalkyl-derivatised benzoylguanidines and their use as a medicament |
| 09/09/2009 | EP1474150B1 Use of 2-alkoxyphenyl-substituted imidazotriazinones for the treatment of cardiac insufficiency |
| 09/09/2009 | EP1432411B1 Timed, sustained release multi-particulate dosage forms of propranolol |
| 09/09/2009 | EP1392326B1 Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| 09/09/2009 | EP1379243B1 Methods for treating metabolic diseases using malonyl-coa decarboxylase inhibitors |
| 09/09/2009 | EP1371370B1 Drugs containing reduced vitamin b2 |
| 09/09/2009 | EP1098962B1 Diacylglycerol acyl transferase proteins |
| 09/09/2009 | CN101525598A Method for purifying human urinary trypsin inhibitor |
| 09/09/2009 | CN101525573A White koji mature vinegar and preparation method thereof |
| 09/09/2009 | CN101525359A Hydroxypropyl isoquercitrin, hydroxypropyl isoquercitrin derivative and preparation method thereof |
| 09/09/2009 | CN101525339A Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias |
| 09/09/2009 | CN101525314A Dihydropyridine calcium antagonist compound, preparation method and medicinal application thereof |
| 09/09/2009 | CN101524545A Hemostatic gel suppository |
| 09/09/2009 | CN101524521A Chinese medicinal composition for treating coronary heart disease and preparation method thereof |
| 09/09/2009 | CN101524514A Medicament for curing central serous chorioretinopathy (CSCR) and preparation method thereof |
| 09/09/2009 | CN101524513A Health pillow drug core |
| 09/09/2009 | CN101524493A Multifunctional Chinese medicine honeyed pill |
| 09/09/2009 | CN101524488A Preparation method of compound bamboo leave flavone dripping pill |
| 09/09/2009 | CN101524487A Chinese medicinal composition for treating hypotension and preparation method thereof |
| 09/09/2009 | CN101524483A Capsule for treating hyperpiesis and apoplexy and preparation method thereof |
| 09/09/2009 | CN101524482A Traditional Chinese medicine composition for treating hypertension |
| 09/09/2009 | CN101524480A Chinese medicinal composition for reducing blood pressure and preparation method thereof |
| 09/09/2009 | CN101524473A Worm grass anticancer longevity pellet and preparation method thereof |
| 09/09/2009 | CN101524470A Traditional Chinese medicine preparation for curing angiocardiopathy stent restenosis and preparation method thereof |
| 09/09/2009 | CN101524469A Chinese herbal medicine compound preparation for treating congestive heart failure and preparation method thereof |
| 09/09/2009 | CN101524454A Preparation process for Chinese yam extract |
| 09/09/2009 | CN101524442A Medicine for treating cancer and preparation method thereof |
| 09/09/2009 | CN101524421A Traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases |
| 09/09/2009 | CN101524414A Chinese medicinal composition for resisting cerebrovascular disease and preparation method thereof |
| 09/09/2009 | CN101524402A Method for extracting volatile oil from Ziziphora Clinopodioides Lam herb by CO2 supercritical extraction technique |
| 09/09/2009 | CN101524393A Preparation method of gypenoside |
| 09/09/2009 | CN101524392A Medicament for curing external hemorrhoid |
| 09/09/2009 | CN101524387A Ixeri sonhifolia injection preparing technology and application thereof for treating cardiovascular and cerebrovascular disease |
| 09/09/2009 | CN101524385A Preparation process for ginseng extract |
| 09/09/2009 | CN101524383A Application of Bochmeria clidemioides Miq var diffusa, compositions of ramie hemorrhoid eliminating capsules, particles and tablets, and preparation method thereof |
| 09/09/2009 | CN101524380A Preparation process for folium ginkgo extract |
| 09/09/2009 | CN101524372A Medicament for treating dermatitis, rhinitis, hemorrhoids, acne and other diseases and production method thereof |
| 09/09/2009 | CN101524362A Application of nucleic acid with CpG motif for preparing anti-fibrotic drug |
| 09/09/2009 | CN101524358A Medical application of psuedo-ginsenoside F11 |
| 09/09/2009 | CN101524354A Protecting function of compound to bandicoot myocardial ischemia reperfusion injury |
| 09/09/2009 | CN101524352A Composition containing 3-methyl-1-phenyl-2-pyrazoline-5-ketone |
| 09/09/2009 | CN101524340A Medicament for treating dermatitis, rhinitis, hemorrhoids, acne and other diseases and production method thereof |
| 09/09/2009 | CN101524331A Polysaccharide-liposome and preparation method and purpose thereof |
| 09/09/2009 | CN101524224A Production method of silk quilt for treating hypertension |
| 09/09/2009 | CN101524190A Disease preventing and curing medicinal mouth-muffle and medicinal composite |
| 09/09/2009 | CN100537770C Von willebrand factor (vWF)-cleaving enzyme |
| 09/09/2009 | CN100537571C Imidazo[1,2-a]pyrazin-8-ylamines, method of making and method of use thereof |
| 09/09/2009 | CN100537546C Novel alkansulfonamides as endothelin antagonists |
| 09/09/2009 | CN100536864C Medicine for treating angiocardiopathy and cerebrovascular disease and its preparing method |
| 09/09/2009 | CN100536857C Soft capsule of extractive from leaves of persimmon and self-emulsifying system for releasing drug |
| 09/09/2009 | CN100536846C Compositions comprising HMG-CoA reductase inhibitor |
| 09/09/2009 | CN100536839C Urea derivatives as integrin alpha 4 antagonists |
| 09/09/2009 | CN100536831C Medication for treating cardiovascular and cerebrovascular diseases |
| 09/09/2009 | CN100536829C Erigeron breviscapus oral caving fast disintegration tablet and its preparation method |
| 09/09/2009 | CN100536691C Compositions containing coenzyme Q10 |
| 09/08/2009 | US7585880 Phenylpropanoic acid derivatives |
| 09/08/2009 | US7585873 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands |
| 09/08/2009 | US7585860 Substituted oxazolidinones and their use in the field of blood coagulation |
| 09/08/2009 | US7585666 genetically engineered chimeras comprising ligand binding domain fused to an effector domain of an apoptosis signaling molecule and second encoding a cis acting regulatory element; for use in/ex vivo |
| 09/08/2009 | US7585658 Staphylococcus aureus antigenic polypeptides and compositions |
| 09/08/2009 | US7585642 Methods for evaluating the quality of a heparin sample |
| 09/08/2009 | US7585623 Syndrome X, metabolic syndrome, multiple risk factor syndrome, insulin resistant syndrome, deadly quartet, and visceral fat syndrome, diabetes, obesity, hypercholesterolemia, and hyperlipoproteinemias, hyperlipidemia, arteriosclerosis, hypertonia, circulatory system disease, hyperphagia |
| 09/08/2009 | US7585507 Nucleic acid molecules and polypeptides for immune modulation |
| 09/08/2009 | CA2519919C Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species |
| 09/08/2009 | CA2463598C Imidazo (4,3-e)-1,2,4-triazolo(1,5-c) pyrimidines as adenosine a2a receptor antagonists |
| 09/08/2009 | CA2387351C Indole derivatives as tyrosine kinase inhibitors |
| 09/08/2009 | CA2386770C Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba |
| 09/08/2009 | CA2342739C Azetidine derivatives, preparation and medicines containing them |
| 09/08/2009 | CA2290745C Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 09/08/2009 | CA2213466C Inhibitors of microsomal triglyceride transfer protein and method |
| 09/03/2009 | WO2009108772A1 Cardiac myocyte morphogenic compositions and methods of use therefor |
| 09/03/2009 | WO2009108722A2 Substituted benzoxazinones |
| 09/03/2009 | WO2009108153A1 Methods and compositions for the regulation of lectin complement pathway (lcp)- associated complement activation in hyperglycemic myocardial damage |
| 09/03/2009 | WO2009107878A1 Vegetable extract containing adenine at high concentration, adenine-containing packed drink containing the vegetable extract, hypotensive composition for oral use containing the vegetable extract as the active ingredient and method of producing the same |
| 09/03/2009 | WO2009107398A1 High-molecular-weight adiponectin measurement method |
| 09/03/2009 | WO2009107389A1 Tricyclic compound |
| 09/03/2009 | WO2009107387A1 2-oxochromene derivative |
| 09/03/2009 | WO2009106894A1 Novel crystalline forms |
| 09/03/2009 | WO2009106752A2 Derivatives of 2-heteroaroyl-imidazol[1,2-a]pyridine, preparation thereof and therapeutic application thereof |
| 09/03/2009 | WO2009106751A2 Derivatives of n-heterocyclic-6-heterocyclic-imidazo[l,2- a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/03/2009 | WO2009106750A2 Derivatives of 6-heterocyclic-imidazo[l,2-a]pyrroine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/03/2009 | WO2009106708A2 Azetidine derivatives, their preparation and their application in therapy |
| 09/03/2009 | WO2009106640A2 N-benzyl imidazole derivatives |
| 09/03/2009 | WO2009106471A2 New angiotensin ii receptor blocker derivatives |
| 09/03/2009 | WO2009106470A2 Angiotensin ii receptor antagonists |
| 09/03/2009 | WO2009106368A1 Method for increasing the activity of the immune system of a mammal at risk of inflammatory diseases |
| 09/03/2009 | WO2009106351A1 Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the b2 adrenergic receptor |
| 09/03/2009 | WO2009106339A1 A method for restoring bmp-receptor signaling in a cell |
| 09/03/2009 | WO2009106121A1 Nutritional compositions for promotion of bone growth and maintenance of bone health comprising extracts of for example rosemary or caraway |
| 09/03/2009 | WO2009049742A3 Use of melanotrophin-potentiating factor as a therapeutic agent |
| 09/03/2009 | WO2009046829A3 Casoxin d as a therapeutic agent |
| 09/03/2009 | WO2009043480A3 Use of leptin (22-56 ) as a therapeutic agent |
| 09/03/2009 | WO2009043469A3 Use of pneumadin as a therapeutic agent |